user

Targeting the CB2 cannabinoid receptor in osteoporosis

被引：2
|
作者：
Bab, Itai [1 ]
Ofek, Orr [1 ]
机构：
[1] Hebrew Univ Jerusalem, Bone Lab, Box 12272, IL-91120 Jerusalem, Israel
来源：
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM | 2011年 / 6卷 / 02期
关键词：
2-arachidonoylglycerol; age-related bone loss; arachidonoylethanoamine; bone density; bone mass; cannabinoid receptors; CB1; CB2; endocannabinoids; osteoporosis;
D O I：
10.1586/EEM.11.2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：135 / 138
页数：4
相关论文
共 50 条
  • [21] The effects of polymorphisms on the functions of CB2 cannabinoid receptor
    Carrasquer, Alex
    Nebane, Ntsang Miranda
    Song, Zhao-Hui
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 230 - 230
  • [22] Antifibrogenic role of the cannabinoid receptor CB2 in the liver
    Julien, B
    Grenard, P
    Teixeira-Clerc, F
    Van Nhieu, JT
    Li, LY
    Karsak, M
    Zimmer, A
    Mallat, A
    Lotersztajn, S
    [J]. GASTROENTEROLOGY, 2005, 128 (03) : 742 - 755
  • [23] CB2 cannabinoid receptor induction in experimental stroke
    Jin, KL
    Mao, XO
    Goldsmith, PC
    Greenberg, DA
    [J]. ANNALS OF NEUROLOGY, 2000, 48 (02) : 257 - 261
  • [24] Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
    Nevalainen, Tapio
    [J]. CURRENT MEDICINAL CHEMISTRY, 2014, 21 (02) : 187 - 203
  • [25] Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor
    Patel, Monica
    Grimsey, Natasha L.
    Banister, Samuel D.
    Finlay, David B.
    Glass, Michelle
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (06):
  • [26] The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists
    Whiteside, G. T.
    Lee, G. P.
    Valenzano, K. J.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2007, 14 (08) : 917 - 936
  • [27] Targeting the CB2 receptor for immune modulation
    Lunn, Charles A.
    Reich, Eva-Pia
    Bober, Loretta
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (05) : 653 - 663
  • [28] Targeting the cannabinoid receptor CB2 in a mouse model of 1-dopa induced dyskinesia
    Rentsch, Peggy
    Stayte, Sandy
    Egan, Timothy
    Clark, Ian
    Vissel, Bryce
    [J]. NEUROBIOLOGY OF DISEASE, 2020, 134
  • [29] Peripheral cannabinoid receptor, CB2, regulates bone mass
    Ofek, O
    Karsak, M
    Leclerc, N
    Fogel, M
    Frenkel, B
    Wright, K
    Tam, J
    Attar-Namdar, M
    Kram, V
    Shohami, E
    Mechoulam, R
    Zimmer, A
    Bab, I
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (03) : 696 - 701
  • [30] In vitro pharmacological characterization of cannabinoid receptor CB2 agonists
    Wang, Yung-Chih
    Lu, Mark
    Riviere, Pierre
    Croston, Glenn
    [J]. INFLAMMATION RESEARCH, 2006, 55 : S121 - S121
12345